AAV Induction Therapy Update: Is Cyclophosphamide (CP) Crucial for Patient Remission? When is it Best to Use Methotrexate (MTX) and Rituximab? Why is Resiniferatoxin (RTX) Better for Newly Diagnosed Patients?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

AAV Induction Therapy Update: Is Cyclophosphamide (CP) Crucial for Patient Remission? When is it Best to Use Methotrexate (MTX) and Rituximab? Why is Resiniferatoxin (RTX) Better for Newly Diagnosed Patients?

By Hospital for Special Surgery FEATURING Lindsay Lally

177 views

August 17, 2020

0 Comments

An Efficacy and Safety Review for Patients With Severe Eosinophilic …

Feat. Y. Goldman

A Treatment Option for Chronic Rhinosinusitis With Nasal Polyps

Feat. C. Franzese

New and Emerging Treatments in Cutaneous Vasculitis

Feat. C. Langford

29:50

Cleveland Clinic Rheumatology

Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Feat. L. Calabrese, G. Hoffman

05:55

Cleveland Clinic Rheumatology

A Case of GPA With Persistent Shortness of Breath, Monitoring Patien…

Feat. A. Villa-Forte

29:43

Cleveland Clinic Rheumatology

GPA and MPA: Is There Still a Role for Conventional Therapy? - Part 2

Feat. C. Langford

43:21

RheumNow

ACR Convergence 2023 Highlights: Abstract Recap Panel - Wednesday

Feat. J. Pope, R. Conway, M. Ramahi, J. Cush

47:24

RheumNow

ACR Convergence 2023 Highlights: Abstract Recap Panel - Monday

Feat. K. Dao, M. Putman, E. Dein, J. Cush

26:48

RheumNow

GPA Management in 2024

Feat. A. Dua

09:09

Naomi Patel

ANCA-Associated Vasculitis Treated with Avacopan versus a Standard P…

17:14

Hospital for Special Surgery

Clinical Spectrum of AAV: Which are Associated Vasculitises? What ar…

Feat. L. Lally

37:35

Cleveland Clinic Rheumatology

GPA and MPA: Is There Still a Role for Conventional Therapy?

30:39

Cleveland Clinic Rheumatology

Herpes Zoster and the Risk of Stroke in Patients with Autoimmune Dis…

Feat. L. Calabrese, C. Calabrese

15:37

Hospital for Special Surgery

AAV Maintenance Therapy Update: Should Remission Maintenance Therapy…

Feat. L. Lally

16:12

Hospital for Special Surgery

C5a Inhibition in AAV: Is there a Strategy to Treat Patients Without…

Feat. L. Lally

07:00

Hospital for Special Surgery

AAV Treatment Update: Algorithm and Main Treatment Principles

Feat. L. Lally

21:00

Cleveland Clinic Rheumatology

33 y/o Female With GPA and Fibrosing Skin Disease

Feat. L. Calabrese

06:05

Hospital for Special Surgery

AAV Treatment Update: Is Plasma Exchange the Ideal Treatment Option …

Feat. L. Lally

06:37

RheumNow

ACR Convergence 2023 Highlights: TMP SMX Prophylaxis in GPA

Feat. J. Cush, J. Pope

24:43

Cleveland Clinic Rheumatology

New and Emerging Treatments in Cutaneous Vasculitis

Feat. C. Langford

09:03

Yusuf Yazici

Behcet Syndrome Update: How Does It Manifest? When Do Symptoms Typic…

16:24

Haner Direskeneli

Login

Login

Join VuMedi

AAV Induction Therapy Update: Is Cyclophosphamide (CP) Crucial for Patient Remission? When is it Best to Use Methotrexate (MTX) and Rituximab? Why is Resiniferatoxin (RTX) Better for Newly Diagnosed Patients?

Related Content